is an international pharmaceutical company that develops, manufactures and markets modern branded generic pharmaceutical products. The Company has leading positions in the pharmaceutical markets of the Czech Republic, Slovakia, Romania, and Turkey and is successfully developing its business in Poland, Russia, Bulgaria, Hungary, the Ukraine and the Baltic States.

Zentiva has been achieving this growth in its traditional as well as new markets by naturally developing the scope of its operations and by means of appropriate acquisitions. In 2009,  Zentiva became member of the Sanofi-Aventis group.

What Do We Supply to Iraq?

  • Neuropathic Pain Medicines
  • Anticonvulsant Medicines
  • Statin Groups (Cholesterol)
  • Antibiotics
  • Antihypertension Medicines
  • Antihistamine

 

 

Bayer Health Care:-

Is a Life Science company with more than 150-year history and core competencies in the areas of health care and agriculture?

The Pharmaceuticals Division focuses on prescription products, especially for cardiology and women’s healthcare, and on specialty therapeutics in the areas of oncology, hematology and ophthalmology. The division also comprises the radiology business, which markets diagnostic imaging equipment together with the necessary contrast agents.

The products are built on a legacy of innovation, and help to enhance diagnostic procedures in a range of MRI, CT and Angiography.

What Do We Supply to Iraq?

  • Contrast Media for CT diagnostic - Ultravist
  • Contrast Media for MRI diagnostic – Magnevist and Gadovist

 

Is a South Korean international dermatological brand which has a distribution network in 42 countries in most continents, Europe, America, Asia, Middle East and Oceania.

Cell Fusion C provides complete skin care solutions exclusively through dermatologists, plastic surgeons, medi-spa, and other skin care professionals around the world.

The products are expertise recommended over 4,000 hospitals and clinics nationwide, safety guaranteed by 11.27 million patients who have undergone laser procedures.

We Supply full range of products to Iraq

is a Turkish company established since 1955, having 300 employees and 100 types of products in the different domains of  dermatology, otorhinolaryngology, orthopedic, physiotherapy with about 20 million units being sold in Turkey and to more than 25 countries all around the world.

It is the leading company in herbal products manufacturing in Turkish Pharmaceutical Industry, Kurtsan İlaçları A.Ş has become the first domestic company to receive patents in Turkey with herbal pastes produced under the brand 'Otacı'.

Productions are performed in Bandirma facilities in Greece  in strict conformity with the GMP rules and ISO standards. Kurtsan Ilaclari A.S always considers the importance of research and development studies and carries out joint projects with TUBITAK “The Scientific and Technological Research Council of Turkey”.

We Supply full range of products to Iraq

Is composed by pharmaceutical companies of private and 100% Portuguese capital. Started its activity in 1980 and covers the entire life cycle of the medicinal products for human use — development, manufacture, promotion and marketing. TECNIMEDE GROUP's strategy is based on a strong investment in Research, Development and Production of Medicinal Products.

It is intended that the results obtained allow to consolidate the Group's position in the Portuguese market and to strengthen exports and internationalization TECNIMEDE GROUP’s commercial activity is based on either direct presence or the establishment of local partnerships in the more than 40 countries where it exports — almost all the European Union countries, as well as several countries in Africa, South America, North America, Asia and the Middle East.

TECNIMEDE GROUP's portfolio includes more than 100 products, as a result of its R&D center, which results in more than 2,500 MAs worldwide.

 

 

 

Is a Polish pharmaceutical and biotechnology company manufacturing almost 580 products offered to patients in 65 countries around the world. Currently, it has over 2000 Associates. Since 2001, the company has invested EUR 232 million in research and development. It establishes scientific research consortia with leading universities and scientific insti¬tutes. The company’s intellectual property is protected by numerous patents. The Adamed is one of ten largest pharmaceutical companies in Poland (source: IMS Health). The company was a pioneer in the country when in 2001 it began research on innovative drugs. Less than four years later, along with the Jagiellonian University, it initiated one of the first industry–academia consortia in Poland. At present, every day over 150 scientists from leading Polish academic centers collaborate with the Adamed in the search for effective therapies.

 

share: